• Thurs news: Moderna posts surprise profit. How Trump victory will affect FTC, FDA. Gilead CAR-T sales stagnate. Sarepta pulls plug on Duchenne candidate. AZ China chief in custody. See more on our front page

BD vs. Bard

anonymous

Guest
So who’s calling the shots now? BD bought Bard yet Bard reps seem to look down on BD reps and Bard leadership is in place in many divisions. Does anyone else find the whole dynamic uncomfortable?
 






I know one thing, it was not a coincidence that the BD reps w access bag got shafted with territory alignments. You would be hard pressed to find many who even live within the geographical area they cover. Not to mention inheriting hospitals with declining business.
 




I know one thing, it was not a coincidence that the BD reps w access bag got shafted with territory alignments. You would be hard pressed to find many who even live within the geographical area they cover. Not to mention inheriting hospitals with declining business.

Care reps have it worse. Less pay and massive territories. Probably have better work life balance though.